Home
/
Cardiff Oncology, Inc.
/
Financials
/
Quarterly
Cardiff Oncology, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Cardiff Oncology, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$86.0K
Nov 4, 2021
Q2
2021
Jun 30, 2021
$68.0K
Aug 5, 2021
Q1
2021
Mar 31, 2021
$72.0K
May 6, 2021
Q3
2021
Sep 30, 2020
$136.0K
Nov 4, 2021
Q2
2021
Jun 30, 2020
$43.0K
Aug 5, 2021
Q1
2021
Mar 31, 2020
$68.0K
May 6, 2021
Q3
2020
Sep 30, 2019
$51.7K
Nov 5, 2020
Q2
2020
Jun 30, 2019
$38.3K
Aug 11, 2020
Q1
2020
Mar 31, 2019
$62.0K
May 7, 2020
Q3
2019
Sep 30, 2018
$88.4K
Nov 7, 2019
Q2
2019
Jun 30, 2018
$111.8K
Aug 8, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$120.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
$121.0K
Jul 29, 2025
Q1
2025
Mar 31, 2025
$109.0K
May 8, 2025
Q3
2025
Sep 30, 2024
$165.0K
Nov 6, 2025
Q2
2025
Jun 30, 2024
$163.0K
Jul 29, 2025
Q1
2025
Mar 31, 2024
$205.0K
May 8, 2025
Q3
2024
Sep 30, 2023
$141.0K
Nov 7, 2024
Q2
2024
Jun 30, 2023
$108.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$83.0K
May 2, 2024
Q3
2023
Sep 30, 2022
$93.0K
Nov 2, 2023
Q2
2023
Jun 30, 2022
$91.0K
Aug 9, 2023
Q1
2023
Mar 31, 2022
$74.0K
May 4, 2023
Q3
2022
Sep 30, 2021
$86.0K
Nov 3, 2022
Q2
2022
Jun 30, 2021
$68.0K
Aug 4, 2022
Q1
2022
Mar 31, 2021
$72.0K
May 5, 2022
Q3
2021
Sep 30, 2020
$136.0K
Nov 4, 2021
Q2
2021
Jun 30, 2020
$43.0K
Aug 5, 2021
Q1
2021
Mar 31, 2020
$68.0K
May 6, 2021
Q3
2020
Sep 30, 2019
$51.7K
Nov 5, 2020
Q2
2020
Jun 30, 2019
$36.9K
Aug 11, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Mar 31, 2019
$162.0K
May 7, 2019
Q3
2018
Sep 30, 2018
$88.4K
Nov 7, 2018
Q2
2018
Jun 30, 2018
$111.8K
Aug 3, 2018
Q1
2019
Mar 31, 2018
$100.1K
May 7, 2019
Q3
2018
Sep 30, 2017
$123.3K
Nov 7, 2018
Q2
2018
Jun 30, 2017
$102.0K
Aug 3, 2018
Q1
2018
Mar 31, 2017
$95.0K
May 8, 2018
Q3
2017
Sep 30, 2016
$89.1K
Nov 9, 2017
Q2
2017
Jun 30, 2016
$103.4K
Aug 9, 2017
Q1
2017
Mar 31, 2016
$120.5K
May 10, 2017
Q3
2016
Sep 30, 2015
$57.3K
Nov 9, 2016
Q2
2016
Jun 30, 2015
$49.3K
Aug 4, 2016
Q1
2016
Mar 31, 2015
$127.0K
May 10, 2016
Q3
2015
Sep 30, 2014
$57.2K
Nov 9, 2015
Q2
2015
Jun 30, 2014
$55.6K
Aug 10, 2015
Q1
2015
Mar 31, 2014
$111.0K
May 5, 2015
Q3
2014
Sep 30, 2013
$43.8K
Nov 6, 2014
Q2
2014
Jun 30, 2013
$49.0K
Aug 7, 2014
Q1
2014
Mar 31, 2013
$119.1K
May 12, 2014
Q3
2013
Sep 30, 2012
$211.5K
Nov 14, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.26M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($13.94M)
Jul 29, 2025
Q3
2025
Jun 30, 2025
($13.94M)
Nov 6, 2025
Q3
2025
Mar 31, 2025
($13.43M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
($13.43M)
May 8, 2025
Q2
2025
Mar 31, 2025
($13.43M)
Jul 29, 2025
Q3
2025
Sep 30, 2024
($11.86M)
Nov 6, 2025
Q3
2025
Jun 30, 2024
($11.78M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($11.78M)
Jul 29, 2025
Q3
2025
Mar 31, 2024
($10.01M)
Nov 6, 2025
Q1
2025
Mar 31, 2024
($10.01M)
May 8, 2025
Q2
2025
Mar 31, 2024
($10.01M)
Jul 29, 2025
Q3
2024
Sep 30, 2023
($9.73M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($11.15M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($11.15M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($11.22M)
May 2, 2024
Q2
2024
Mar 31, 2023
($11.22M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($11.22M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($8.57M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($10.44M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.97M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($14.78M)
Jul 29, 2025
Q1
2025
Mar 31, 2025
($14.38M)
May 8, 2025
Q3
2025
Sep 30, 2024
($12.60M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($12.55M)
Jul 29, 2025
Q1
2025
Mar 31, 2024
($10.93M)
May 8, 2025
Q3
2024
Sep 30, 2023
($10.82M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($12.21M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($12.05M)
May 2, 2024
Q3
2023
Sep 30, 2022
($8.99M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($10.44M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($11.07M)
May 4, 2023
Q3
2022
Sep 30, 2021
($7.00M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($6.89M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($5.44M)
May 5, 2022
Q3
2021
Sep 30, 2020
($4.36M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($4.10M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($4.12M)
May 6, 2021
Q3
2020
Sep 30, 2019
($4.21M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($4.22M)
Aug 11, 2020